CGM supports diabetes self-management and related behavior modification. We investigated the impact of CGM on psychosocial health and lifestyle behaviors in a prediabetes population.
Glucose data were collected in an observational 12-week US study involving adults with prediabetes or at high risk for diabetes (Study 1, N=47). Patient-reported outcomes (PROs) assessing psychosocial health were collected at baseline and study-end. A subset of Study 1 participated in a qualitative follow-up (Study 2, N=17) and shared their experiences using the Dexcom G6. Qualitative data were analyzed using thematic and content analyses.
Study 1 participants were 63% female, 59% White, median (IQR) age 54 (44, 66), BMI 32 (26, 38) kg/m2, medication count=6 (3, 10). TIR remained high for the duration of the study (100% (96, 100)). PROs reflected significantly improved emotional well-being and self-efficacy for health management and reduced perceived severity of prediabetes using Dexcom CGM. Primary qualitative themes are presented in Table 1.
Use of Dexcom CGM was associated with improved psychosocial health and self-care behaviors in participants with prediabetes. Findings emphasize the value of Dexcom CGM as a behavior modification tool irrespective of individuals’ diabetes and glycemic status.
M.A. Crawford: Employee; Dexcom, Inc. C. Hicks: Employee; Dexcom, Inc. H. Singh: Employee; Dexcom, Inc.
